Pulling SEC filings + quote and writing the call…
APVO
Aptevo Therapeutics Inc.
Next earnings Aug 10, 2026 · consensus $-6.14 EPS
Last earnings -1.4% on 2026-05-13
$4.74
▼ -0.32%$4.75▼ -92.79%
over 1Y
L $3.96EODHDH $92.34
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.3%
1W+1.1%
1M-2.9%
3M+5.8%
YTD-49.4%
1Y-92.8%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.56x); but revenue fell -74.7% YoY.
Aptevo Therapeutics Inc. shows $3.11M in FY2022 revenue (-74.7% YoY), a -833.9% net margin, and -149.4% ROE.
Sources: SEC EDGAR (CIK 0001671584, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 1:30:24 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.